Join to access to all OVN content. Join for Free
From Interactions to Impact: How Medical Affairs Can Prove Its Value
Medical Affairs SMART framework scientific ROI share of scientific voice business case for SMART metrics insights versus impact measurement metric analysis strategic impact message alignment ROI influence of Medical Affairs implementation of SMA

From Interactions to Impact: How Medical Affairs Can Prove Its Value


Share This Article


Summary

In this episode, Tom Caravela is joined by Lusine Kodagolian to discuss how to measure the value of medical affairs. They explore the SMART framework, emphasizing its application in measuring scientific ROI and share of scientific voice. The discussion highlights the balance of various metrics and how to build a business case for SMART metrics, especially for smaller or early-stage companies. The conversation covers insights versus impact measurement and the implementation of new strategies. Consistency, trends, and feedback in metric analysis are underscored as essential elements. The episode concludes with actionable steps for integrating these strategies in medical affairs.

Key Points

  • Medical Affairs can enhance their strategic impact by adopting the SMART framework to measure specific, relevant, and time-bound goals.
  • Tracking scientific share of voice and message alignment ROI provides deeper insights into the true influence of Medical Affairs beyond traditional activity metrics.
  • Even smaller teams with limited resources can begin implementing SMART measurements by starting simple, focusing on one key message, and consistently tracking its adoption and impact.

Click for Source
Medical Affairs, SMART framework, scientific ROI, share of scientific voice, business case for SMART metrics, insights versus impact measurement, metric analysis, strategic impact, message alignment ROI, influence of Medical Affairs, implementation of SMA

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Empowering people to drive medical affairs performance with AI
Partner Avatar Envision Pharma Group

Empowering people to drive medical affairs performance with AI

Article
Medical affairs: The power behind redefining commercialization
Partner Avatar Envision Pharma Group

Medical affairs: The power behind redefining commercialization

Podcast
The Struggle With KOL Access in Todays World
Partner Avatar MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper

The Struggle With KOL Access in Todays World

Podcast
Interim Impact The Rise of Fractional Medical Affairs Roles in Pharmas New Reality
Partner Avatar MSL Talk: Tom Caravela, Daniel Snyder

Interim Impact The Rise of Fractional Medical Affairs Roles in Pharmas New Reality

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Explore OVN